[April 22, 2014] |
|
Research and Markets: Global Parkinson's Disease Therapeutics Pipeline Review 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/gnp5tm/parkinsons)
has announced the addition of the "Parkinson's
Disease - Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic
development for Parkinson's Disease, complete with comparative analysis
at various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for
Parkinson's Disease and special features on late-stage and discontinued
projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class prodcts.
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Parkinson's Disease
-
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
-
The report reviews key players involved in the therapeutics
development for Parkinson's Disease and enlists all their major and
minor projects
-
The report summarizes all the dormant and discontinued pipeline
projects
-
A review of the Parkinson's Disease products under development by
companies and universities/research institutes based on information
derived from company and industry-specific sources
-
Pipeline products coverage based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
-
A detailed assessment of monotherapy and combination therapy pipeline
projects
-
Coverage of the Parkinson's Disease pipeline on the basis of target,
MoA, route of administration and molecule type
-
Latest news and deals relating related to pipeline products
Key Topics Covered:
1. Introduction
2. Parkinson's Disease Overview
3. Therapeutics Development
-
Therapeutics under Development by Companies
-
Therapeutics under Investigation by Universities/Institutes
-
Pipeline Products Glance
-
Products under Development by Companies
-
Products under Investigation by Universities/Institutes
-
Companies Involved in Therapeutics Development
-
Therapeutics Assessment
4. Drug Profiles
-
Recent Pipeline Updates
-
Dormant Projects
-
Discontinued Products
-
Product Development Milestones
5. Appendix
For more information visit http://www.researchandmarkets.com/research/gnp5tm/parkinsons
[ Back To TMCnet.com's Homepage ]
|